MARKS TEY HEALTHCARE LIMITED


Director	OSORIO RODRIGUEZ, Jose


Registered Address	89 London Road
	Marks Tey
	Colchester
	CO6 1EB


Registered Number	08941985 (England and Wales)

Balance Sheet as at
31 December 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Investments	3		599,305		599,305
			599,305		599,305
Current assets
Cash at bank and on hand		20,911		21,278
		20,911		21,278
Creditors amounts falling due within one year	5	(338,988)		(305,086)
Net current assets (liabilities)			(318,077)		(283,808)
Total assets less current liabilities			281,228		315,497
Creditors amounts falling due after one year	6		(80,448)		(105,857)
Net assets			200,780		209,640
Capital and reserves
Called up share capital			100		100
Profit and loss account			200,680		209,540
Shareholders' funds			200,780		209,640

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 3 September 2026, and are signed on its behalf by:

OSORIO RODRIGUEZ, Jose
Director
Registered Company No. 08941985

MARKS TEY HEALTHCARE LIMITED

Notes to the Financial Statements
for the year ended 31 December 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Investments
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

Investments

Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	1		1

3.	Fixed asset investments

	Investments in groups¹	Total
	£	£
Cost or valuation
At 01 January 25	599,305	599,305
At 31 December 25	599,305	599,305
Net book value
At 31 December 25	599,305	599,305
At 31 December 24	599,305	599,305

	Notes
	¹Investments in group undertakings and participating interests

4.	Debtors: amounts due within one year

5.	Creditors: amounts due within one year

	2025	2024
	£	£
Bank borrowings and overdrafts	29,559	29,559
Amounts owed to related parties	290,577	199,676
Other creditors	18,852	75,851
Total	338,988	305,086


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

6.	Creditors: amounts due after one year

	2025	2024
	£	£
Bank borrowings and overdrafts	80,448	105,857
Total	80,448	105,857

7.	Related party transactions
	At the yearend, the company owed £290,577 (2024: £199,676) to Marks Tey Pharmacy Ltd. The companies are related as Marks Tey Healthcare Ltd owns 100% share capital of Marks Tey Pharmacy Ltd.